North Star Asset Management Inc. raised its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 4.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 48,571 shares of the medical research company’s stock after buying an additional 1,932 shares during the period. North Star Asset Management Inc.’s holdings in Thermo Fisher Scientific were worth $7,461,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Independent Portfolio Consultants Inc. boosted its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares during the last quarter. Sharkey Howes & Javer boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the last quarter. Washington Trust Bank boosted its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. Washington Trust Bank now owns 2,210 shares of the medical research company’s stock worth $339,000 after buying an additional 10 shares during the last quarter. Beacon Trust Co. boosted its stake in shares of Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock worth $341,000 after buying an additional 12 shares during the last quarter. Finally, Dumont & Blake Investment Advisors LLC boosted its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock worth $849,000 after buying an additional 15 shares during the last quarter. 87.60% of the stock is currently owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc (TMO) traded up 0.58% on Monday, reaching $174.24. 402,611 shares of the company traded hands. The firm has a market capitalization of $67.97 billion, a P/E ratio of 30.36 and a beta of 1.06. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $182.87. The stock has a 50-day moving average price of $176.78 and a 200 day moving average price of $165.46.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. Thermo Fisher Scientific’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.03 EPS. Analysts anticipate that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

ILLEGAL ACTIVITY WARNING: “North Star Asset Management Inc. Has $7.46 Million Position in Thermo Fisher Scientific Inc (TMO)” was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/north-star-asset-management-inc-has-7-46-million-position-in-thermo-fisher-scientific-inc-tmo/1487467.html.

A number of brokerages have issued reports on TMO. Jefferies Group LLC boosted their target price on shares of Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a report on Friday, April 28th. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Saturday, June 10th. Wells Fargo & Company reissued an “outperform” rating and set a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 13th. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Finally, Bank of America Corporation reissued a “buy” rating and set a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. One investment analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $188.56.

In other Thermo Fisher Scientific news, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total value of $805,773.44. Following the sale, the insider now directly owns 29,200 shares in the company, valued at approximately $5,018,896. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction on Monday, June 5th. The shares were sold at an average price of $176.26, for a total transaction of $440,650.00. Following the completion of the sale, the chief financial officer now owns 37,790 shares in the company, valued at $6,660,865.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,188 shares of company stock worth $4,702,223. 0.49% of the stock is currently owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.